Detail akcie Simulatns Plus online

Business Summary: Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
Financial Summary: BRIEF: For the three months ended 30 November 2025, Simulations Plus Inc revenues decreased 3% to $18.4M. Net income increased from $206K to $676K. Revenues reflect Software segment decrease of 17% to $8.9M, Americas segment decrease of 7% to $13.4M. Net income reflects General and administrative decrease of 25% to $4M (expense), Interest income increase of 68% to $267K (income).